MedTrace Logo

The Better, Harder, Faster, Stronger Study

NCT07220512 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 35

Last updated 2025-10-24

No results posted yet for this study

Summary

The purpose of this study is to evaluate changes in the electronic Frailty Index (eFI) score following 3-4 cycles of neoadjuvant chemotherapy (NACT) in participants with advanced ovarian and endometrial cancer.

Conditions

Interventions

OTHER

data collection

PROs, historical and longitudinal data collection and eFI calculation

Sponsors & Collaborators

  • Atrium Health Wake Forest Baptist

    collaborator OTHER

  • Wake Forest University Health Sciences

    lead OTHER

Principal Investigators

  • Anna Kuan-Celarier, MD · Wake Forest University Health Sciences

Eligibility

Min Age
55 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-07-28
Primary Completion
2026-11-30
Completion
2027-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07220512 on ClinicalTrials.gov